Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Prepaid Assets (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Prepaid Assets for 5 consecutive years, with $1.7 million as the latest value for Q4 2024.

  • On a quarterly basis, Prepaid Assets rose 60.95% to $1.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.7 million, a 60.95% increase, with the full-year FY2024 number at $1.7 million, up 60.95% from a year prior.
  • Prepaid Assets was $1.7 million for Q4 2024 at Ensysce Biosciences, up from $1.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.7 million in Q4 2024 to a low of $48325.0 in Q3 2020.
  • A 5-year average of $351661.8 and a median of $141212.5 in 2022 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: plummeted 52.9% in 2021, then surged 500.73% in 2022.
  • Ensysce Biosciences' Prepaid Assets stood at $157483.0 in 2020, then tumbled by 52.9% to $74173.0 in 2021, then soared by 500.73% to $445583.0 in 2022, then skyrocketed by 139.62% to $1.1 million in 2023, then skyrocketed by 60.95% to $1.7 million in 2024.
  • Per Business Quant, the three most recent readings for ENSC's Prepaid Assets are $1.7 million (Q4 2024), $1.1 million (Q4 2023), and $151016.0 (Q1 2023).